CALR and cardiomyopathy: Calreticulin increases cardiomyocyte endoplasmic reticulum/sarcoplasmic reticulum Ca2+ capacity and mechanical work potential, but at the same time may lead to cardiomyopathy, reduce cell–cell communication, and induce increased collagen deposition and cardiac fibrosis [17].